Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Andersson

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Frontiers in Digital Health|December 24, 2021
The Clinical Course of Alcohol Use Disorder Depicted by Digital BiomarkersAndreas Zetterström, Markku D Hämäläinen, Maria Winkvist, et al.
Plos One|July 14, 2022
Processing incomplete questionnaire data into continuous digital biomarkers for addiction monitoringAndreas Zetterström, Gunnar Dahlberg, Sara Lundqvist, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 3, 2020
Breathalyser-Based eHealth Data Suggest That Self-Reporting of Abstinence Is a Poor Outcome Measure for Alcohol Use Disorder Clinical TrialsMarkku D Hämäläinen, Andreas Zetterström, Maria Winkvist, et al.
International Journal of Oncology|December 28, 2011
Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell linePavel Barta, Jennie Malmberg, Ludmila Melicharova, et al.
FEBS Letters|July 4, 2026
Identification of a Shiga toxin A-derived peptide internalized into Gb3 receptor-bearing cells via interaction with the Shiga toxin B subunitGiulia Opassi, João C Encarnação, Valeria Napolitano, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2012
[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumoursAnna Orlova, Camilla Hofström, Joanna Strand, et al.
Protein Engineering|May 30, 2002
QSAR studies applied to the prediction of antigen-antibody interaction kinetics as measured by BIACORELaurence Choulier, Karl Andersson, Markku D Hämäläinen, et al.
Plos One|February 7, 2015
Deciphering the stepwise binding mode of HRG1β to HER3 by surface plasmon resonance and interaction mapCarmen Peess, Leopold von Proff, Sabine Goller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumorsVladimir Tolmachev, Fredrik Y Nilsson, Charles Widström, et al.
Biosensors|March 26, 2025
Regulatory Effects of RNA-Protein Interactions Revealed by Reporter Assays of Bacteria Grown on Solid MediaGuillermo Pérez-Ropero, Roswitha Dolcemascolo, Anna Pérez-Ràfols, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Digital Health|December 24, 2021
The Clinical Course of Alcohol Use Disorder Depicted by Digital BiomarkersAndreas Zetterström, Markku D Hämäläinen, Maria Winkvist, et al.
Plos One|July 14, 2022
Processing incomplete questionnaire data into continuous digital biomarkers for addiction monitoringAndreas Zetterström, Gunnar Dahlberg, Sara Lundqvist, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 3, 2020
Breathalyser-Based eHealth Data Suggest That Self-Reporting of Abstinence Is a Poor Outcome Measure for Alcohol Use Disorder Clinical TrialsMarkku D Hämäläinen, Andreas Zetterström, Maria Winkvist, et al.
International Journal of Oncology|December 28, 2011
Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell linePavel Barta, Jennie Malmberg, Ludmila Melicharova, et al.
FEBS Letters|July 4, 2026
Identification of a Shiga toxin A-derived peptide internalized into Gb3 receptor-bearing cells via interaction with the Shiga toxin B subunitGiulia Opassi, João C Encarnação, Valeria Napolitano, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2012
[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumoursAnna Orlova, Camilla Hofström, Joanna Strand, et al.
Protein Engineering|May 30, 2002
QSAR studies applied to the prediction of antigen-antibody interaction kinetics as measured by BIACORELaurence Choulier, Karl Andersson, Markku D Hämäläinen, et al.
Plos One|February 7, 2015
Deciphering the stepwise binding mode of HRG1β to HER3 by surface plasmon resonance and interaction mapCarmen Peess, Leopold von Proff, Sabine Goller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumorsVladimir Tolmachev, Fredrik Y Nilsson, Charles Widström, et al.
Biosensors|March 26, 2025
Regulatory Effects of RNA-Protein Interactions Revealed by Reporter Assays of Bacteria Grown on Solid MediaGuillermo Pérez-Ropero, Roswitha Dolcemascolo, Anna Pérez-Ràfols, et al.
Pageof 7